Sign up for a free trial now

Login
Subscribe
Take a FREE Trial

About Us
Contact us
RSS

24 May 2013

Search

The Pharma Letter

Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe

Cerenis Therapeutics Articles

There are no articles related to Cerenis Therapeutics.

Hot Topics
Most Read

Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
Boehringer Ingelheim gets FDA warning letter on cGMP failures
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients

Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
Boehringer Ingelheim gets FDA warning letter on cGMP failures
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients

© 2013 thepharmaletter.com

Home
RSS
About Us
Subscribe
Terms and Conditions
Article Archive

Site powered by WORKSsitebuilder CMS